Has Mark Eskenazi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $93,381 in general payments to Mark Eskenazi, MD across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Mark Eskenazi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Mark Eskenazi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Mark Eskenazi, MD

Orthopaedic Surgery of the Spine · Delray Beach, FLNPI 1386640852

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $77,363 of the $93,381 with a category attached, or 82.8%. 12 manufacturers reported payments, led by Globus Medical at 56.3% of the total. Reporting peaked in 2019 at $38,384 and has fallen 98.9% since, to $409 in 2025.

$93,381in general payments, 2019–2025

Across 80 payments — averaging $1167.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Globus Medical$53K
Surgalign Spine Technologies, Inc.$33K
Johnson & Johnson$5K
Spinal Elements, Inc.$1K
Acera Surgical, Inc.$601
Sanara Medtech Inc.$374
plus $648 from 6 others

$27,238in research payments, 2019–2025

Across 4 payments — averaging $6809.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Surgalign Spine Technologies, Inc.$27K
Spinal Elements, Inc.$598

What the payments were for

Royalty or licence$77,36383%
Consulting fees$6,2057%
Travel & lodging$6,0436%
Food & beverage$3,7694%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Globus Medical(2 entities)	15	$52,567
Surgalign Spine Technologies, Inc.	33	$33,345
Johnson & Johnson(2 entities)	3	$4,615
Spinal Elements, Inc.	9	$1,232
Acera Surgical, Inc.	4	$601
Sanara Medtech Inc.	4	$374
Stryker	6	$341
Alphatec Spine, Inc	1	$141
Medtronic	2	$90
Medicrea USA, Corp.	1	$32
Abbott	1	$24
Merck	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ELLIPSE$50,258
STREAMLINE MIS SPINAL FIXATION SYSTEM$19,415
FORTILINK-C IBF SYSTEM$5,580
ARAI SURGICAL NAVIGATION SYSTEM$4,788
DERMABOND$4,500
STREAMLINE TL SPINAL FIXATION SYSTEM$2,644
FORTILINK-TC TIPLUS$2,514
STREAMLINE* OCT OCCIPITO-CERVICO-THORACIC SYSTEM$2,514
ELLIPSE Addition -C$2,111
Medical Devices$918
Restrata Wound Matrix$601
Medical Device$338
CellerateRx$335
FUSION LATERAL DISC PREP SET$220
Invictus MIS$141

How this compares

$93,381 in reported general payments places this provider in the 65th percentile of 159 orthopaedic surgery of the spine providers in Florida.

See all orthopaedic surgery of the spine providers in Florida →

Medicare billing

Part B allowed, 2024

$796,525

Medicare patients

705

Services billed

2,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	44	$476
Tramadol Hcl	76	$426
Meloxicam	54	$212
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	19	$185
Methylprednisolone	32	$171
Cephalexin	29	$66
Diazepam	20	$39

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Delray Beach

Edward ChungDelray Beach$125K
Harry ShufflebargerMiami$3.5M
Paul KellerMelbourne$3.4M
Thomas SweeneySarasota$2.3M
Geoffrey CronenTampa$2.2M
James BillysOdessa$1.9M
Mark DekutoskiDestin$1.8M
Farhan SiddiqiOdessa$1.7M
Samuel JosephSafety Harbor$1.7M
Thomas ErricoMiami$1.6M

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →